Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax + Azacitidine in Newly Diagnosed AML in India
NCT07044687Phase 4Recruiting
- Sponsor
- AbbVie Inc.
- Start
- Jul 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of venetoclax in acute myeloid leukemia (AML), sponsored by AbbVie Inc.. Started Jul 2025; status: recruiting.
02
Drugs
venetoclax
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT07044687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07044687.